Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
36
FBIO Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
-3.66%
Day range:
$1.68 - $1.83
52-week range:
$1.36 - $2.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.34x
P/B ratio:
2.24x
Volume:
200.6K
Avg. volume:
347.9K
1-year change:
-10.42%
Market cap:
$47.5M
Revenue:
$84.5M
EPS (TTM):
-$13.27
Earnings Data
Next earnings date for FBIO
May 15
2025
Most recent earnings per share
-$0.76
Missed by $0.49
(Nov 14/2024)
Consensus Estimate
-$0.27
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FBIO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/15/2025 | Q1 | $11.8M | -- | -- | -- | -- |
| 03/18/2025 | Q4 | $16.3M | -- | -- | -$0.75 | -- |
| 11/14/2024 | Q3 | $32.2M | $14.6M | -$0.76 | -$0.27 | -$0.49 |
| 08/14/2024 | Q2 | $14.8M | $14.9M | -$10.95 | -- | -- |
| 05/14/2024 | Q1 | $14.1M | $13M | -$1.03 | -- | -- |
| 03/18/2024 | Q4 | $15.1M | $19.9M | -$0.53 | -$1.49 | $0.96 |
| 11/07/2023 | Q3 | $15.9M | $34.8M | -$0.94 | -$1.50 | $0.56 |
| 08/14/2023 | Q2 | $17.5M | $17.4M | -$3.65 | -$0.90 | -$2.75 |
| 05/15/2023 | Q1 | $20.3M | $12.4M | -$3.47 | $0.45 | -$3.92 |
| 03/30/2023 | Q4 | $22.1M | $16.4M | -$4.81 | -$0.08 | -$4.74 |
| 09/30/2022 | Q3 | $21.6M | $16.5M | -$4.11 | -$1.05 | -$3.06 |
| 08/11/2022 | Q2 | -- | $18.9M | -$3.90 | -- | -- |
| 05/10/2022 | Q1 | -- | $23.9M | -$2.70 | -- | -- |
| 03/28/2022 | Q4 | -- | $18.3M | -$5.70 | -- | -- |
| 11/04/2021 | Q3 | -- | $21.1M | -$3.90 | -- | -- |
| 08/16/2021 | Q2 | -- | $17.8M | -$0.60 | -- | -- |
| 05/06/2021 | Q1 | -- | $11.6M | -$1.65 | -- | -- |
| 03/31/2021 | Q4 | -- | $13.7M | -$0.90 | -- | -- |
| 11/09/2020 | Q3 | -- | $9.5M | -$3.00 | -- | -- |
| 08/05/2020 | Q2 | -- | $9.5M | -$2.85 | -- | -- |
| 05/06/2020 | Q1 | -- | $12.9M | -$2.85 | -- | -- |
| 03/11/2020 | Q4 | -- | $11.1M | -$4.05 | -- | -- |
| 11/04/2019 | Q3 | -- | $9.8M | -$3.30 | -- | -- |
| 08/09/2019 | Q2 | -- | $9.3M | -$3.60 | -- | -- |
| 03/31/2019 | Q1 | -- | $6.5M | $0.30 | -- | -- |
| 12/31/2018 | Q4 | -- | $9M | -$8.70 | -- | -- |
| 09/30/2018 | Q3 | -- | $5.2M | -$5.55 | -- | -- |
| 06/30/2018 | Q2 | -- | $6.8M | -$7.50 | -- | -- |
| 03/31/2018 | Q1 | -- | $5.9M | -$7.35 | -- | -- |
| 12/31/2017 | Q4 | -- | -$125M | -$3.30 | -- | -- |
| 09/30/2017 | Q3 | -- | $46.9M | -$10.05 | -- | -- |
| 06/30/2017 | Q2 | -- | $50.7M | -$6.45 | -- | -- |
| 03/31/2017 | Q1 | -- | $44.7M | -$4.50 | -- | -- |
| 12/31/2016 | Q4 | -- | $12.6M | -$6.60 | -- | -- |
| 09/30/2016 | Q3 | -- | $975K | -$4.80 | -- | -- |
| 06/30/2016 | Q2 | -- | $2.2M | -$4.65 | -- | -- |
| 03/31/2016 | Q1 | -- | $660K | -$4.65 | -- | -- |
| 12/31/2015 | Q4 | -- | $338K | -$4.65 | -- | -- |
| 09/30/2015 | Q3 | -- | $25K | -$6.90 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$2.40 | -- | -- |
| 03/31/2015 | Q1 | -- | $500K | -$4.65 | -- | -- |
Fortress Biotech Earnings Questions
-
How Much did Fortress Biotech Generate in Revenue Last Quarter?
Fortress Biotech reported $14.6M worth of top line sales in its most recent quarter.
-
Did Fortress Biotech Beat Earnings Last Quarter?
Fortress Biotech announced earnings per share of -$0.76 which represents a miss of analyst forecast a -$0.27 per share.
-
Is Fortress Biotech Profitable?
Fortress Biotech reported $9.3M that represents $0.47 per share over the last quarter.
-
What is the Analyst Consensus for Fortress Biotech EPS Next Year?
Fortress Biotech's earnings are forecast to decrease from -$8.47 per share to -$3.28 per share next year representing a decrease of -89.73%.
-
When is Fortress Biotech's Earnings Date?
Fortress Biotech's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.28% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 6.21% over the past day.
Buy
93
ESLT alert for Mar 19
Elbit Systems [ESLT] is up 0.44% over the past day.
